Stockreport

Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024 [Yahoo! Finance]

Xenetic Biosciences, Inc.  (XBIO) 
NASDAQ:AMEX Investor Relations: ir.xeneticbio.com
PDF FRAMINGHAM, MA / ACCESSWIRE / October 22, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing [Read more]